Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients | MicrobiomeTrials

← Back to trials

NCT06690398

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2024-11-22Est. Completion: 2027-06-21

Enrollment target: 160 participants

Locations

Harmonex Neuroscience Research, Dothan, Alabama, United States
Southwest Autism Research and Resource Center, Phoenix, Arizona, United States
Advanced Research Center Inc, Anaheim, California, United States
Excell Research Inc, Oceanside, California, United States
Inland Psychiatric Medical Group Inc, Redlands, California, United States
Buena Park Research, Upland, California, United States
Next Level Clinical Trials, LLC, West Covina, California, United States
MCB Clinical Research Centers LLC, Colorado Springs, Colorado, United States
Royal Palm Clinical Research, Fort Myers, Florida, United States
Sarkis Clinical Trials, Gainesville, Florida, United States
Green Leaf Clinical Trials, Jacksonville, Florida, United States
Columbus Clinical Services LLC, Miami, Florida, United States
South Florida Research Phase I-IV, Miami, Florida, United States
Diverse Clinical Research LLC, Miami, Florida, United States
Anchor Medical Research LLC, Miami, Florida, United States
Links Clinical Trials, Miami, Florida, United States

Other microbiome trials you might be interested in

Iterative Redesign of a Multifaceted Implementation Strategy for a School-based Behavioral Skills Intervention (RUBI)Completed

Autism Spectrum Disorder

The increased prevalence of autism spectrum disorder (1 in 36 youth) in the United States along with the exorbitant cost…

Seattle, United StatesCompleted Mar 31, 2026

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsPhase 3Recruiting

Irritability Associated With Autism Spectrum Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with …

Little Rock, United StatesEst. completion Jun 21, 2027

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.